- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02169128
Severe Soft Tissue Infections: Perspectives of Patients and Significant Others
August 13, 2018 updated by: Göteborg University
Severe necrotizing soft tissue infection (NSTI), including necrotizing fasciitis, is a life threatening infection that spreads quickly to cutis, sub-cutis, fasciae and muscles.
Approximately 40% of all patients with infections caused by S. Pyogenes develop a streptococcal toxic-shock syndrome.
In these cases the mortality rates exceed 40% in spite of adequate treatment with antimicrobials.
Due to the rapid progress, the extensive damage on soft tissues and high risk of death, the microbes are called "flesh-eating bacteria".
The present study is a spin-off of the larger EU funded INFECT study, looking at the experiences of patient and family to understand the impact on every day life.
The present prospective mixed methods study has the potential to provide important knowledge regarding the occurrence of early signs and symptoms of NSTI, quality of life 6 and 24 months after diagnosis, and how the care and treatment can be optimized and organized in a person/patient and family centered way.
The study also aims at validate the SF 36 questionnaire for this group of patients.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 4131
- Recruiting
- Rigshospitalet
-
Contact:
- Ingrid Egerod, RN, prof
- Email: ingrid.egerod@regionh.dk
-
Principal Investigator:
- Martin Bruun Madsen, MD
-
-
-
-
-
Gothenburg, Sweden, 416 85
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Sven-Egron Thörn, MD, ass prof
- Phone Number: +46313434000
- Email: sven-egron.thorn@vgregion.se
-
Principal Investigator:
- Annette Erichsen Andersson, RN, PhD
-
Solna, Sweden, 171 64
- Recruiting
- Karolinska Universitetssjukhuset
-
Contact:
- Folke Lind, MD, PhD
- Phone Number: +46851775557
- Email: folke.lind@karolinska.se
-
Principal Investigator:
- Ann-Mari Fagerdahl, RN, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients treated for necrotizing fasciitis at the three study sites
Description
Inclusion Criteria:
- Patients diagnosed with necrotizing fasciitis and their significant others
- Age above 18 yrs
Exclusion Criteria:
- Persons with dementia or severe psychiatric illness
- Persons that do not master the Scandinavian language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients and their significant others
Patients affected by necrotizing fasciitis and their significant others
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: 6 months
|
Quantitative - health related quality of life Qualitative - patient experience
|
6 months
|
|
Quality of life
Time Frame: 24 months
|
Quantitative - health related quality of life Qualitative - patient experience
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life of significant others
Time Frame: 6 months
|
Quantitative - health related quality of life Qualitative - experience of significant others
|
6 months
|
|
Quality of life of significant others
Time Frame: 24 months
|
Quantitative - health related quality of life Qualitative - experience of significant others
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sven-Egron Thörn, MD, ass prof, Sahlgrenska University Hospital, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
June 19, 2014
First Submitted That Met QC Criteria
June 20, 2014
First Posted (Estimate)
June 23, 2014
Study Record Updates
Last Update Posted (Actual)
August 14, 2018
Last Update Submitted That Met QC Criteria
August 13, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SSTI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Necrotizing Fasciitis
-
Assiut UniversityNot yet recruitingNecrotizing FascitisEgypt
-
Spectrum Health HospitalsNot yet recruitingNecrotizing FascitisUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedNecrotising FasciitisUnited States
-
Hospices Civils de LyonUnknownCervical Necrotizing FasciitisFrance
-
Tehran University of Medical SciencesCompletedNecrotizing FasciitisIran, Islamic Republic of
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingNecrotizing Soft-tissue InfectionsFrance
-
Benjamin T. MillerRecruitingThe Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®Necrotizing Soft Tissue Infection | Necrotizing FascitisUnited States
-
Eric R. HendersonNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingNecrotizing FascitisUnited States
-
Dow University of Health SciencesCompleted
-
University Hospital, GhentResearch Foundation FlandersCompletedBurns | Necrotizing Fascitis | Full Thickness BurnBelgium